Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex.
Wang X, Xie Q, Ji Y, Yang J, Shen J, Peng F, Zhang Y, Jiang F, Kong X, Ma W, Liu D, Zheng L, Qing C, Lang JY.
Wang X, et al. Among authors: liu d.
Cell Rep. 2023 Jan 31;42(1):111972. doi: 10.1016/j.celrep.2022.111972. Epub 2023 Jan 14.
Cell Rep. 2023.
PMID: 36641751
Free article.